Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.39 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.37 |
| ▸ | RRM1 | P23921 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.36 |
| ▸ | ACHE | P22303 | 3/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.35 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.35 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.35 |
| ▸ | TLR2 | O60603 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL368705 | 0.91 | DPP7 (0.40) | DPP7SIRT6SIRT1SPHK1NOD1 | |
| SCHEMBL23549407 | 0.90 | TSHR (0.41) | DPP7SIRT6SIRT1SPHK1NOD1 | |
| SCHEMBL3043418 | 0.90 | TSHR (0.41) | DPP7SIRT6SIRT1SPHK1NOD1 | |
| Hydrochloric Acid SCHEMBL3043413 | 0.88 | SPHK1 (0.42) | DPP7SIRT6SIRT1SPHK1NOD1 | |
| Hydrochloric Acid SCHEMBL10931245 | 0.88 | SPHK1 (0.42) | DPP7SIRT6SIRT1SPHK1NOD1 | |
| SCHEMBL23752089 | 0.88 | EPHX1 (0.44) | DPP7SIRT6SIRT1SPHK1NOD1 | |
| SCHEMBL27743938 | 0.88 | EPHX1 (0.44) | DPP7SIRT6SIRT1SPHK1NOD1 | |
| SCHEMBL23752090 | 0.88 | EPHX1 (0.44) | DPP7SIRT6SIRT1SPHK1NOD1 | |
| SCHEMBL427041 | 0.86 | ACHE (0.43) | SIRT6SIRT1NOD1EPHX1ACHE | |
| SCHEMBL1939288 | 0.85 | TSHR (0.39) | DPP7SIRT6SIRT1SPHK1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8937100-B2 | Cosmetic composition containing calcium citrate and N-acylated aminoalcohol derivative | COGNIS IP MANAGEMENT GMBH (DE) | 2015-01-20 | — | — | US | disclosed |
| US-20140086863-A1 | Cosmetic Composition | COGNIS IP MANAGEMENT GMBH (DE) | 2014-03-27 | — | — | US | disclosed |
| US-8592484-B2 | Cosmetic composition containing calcium citrate and N-acylated aminoalcohol derivative to prevent dry skin and signs of cutaneous ageing | COGNIS IP MANAGEMENT GMBH (DE) | 2013-11-26 | — | — | US | disclosed |
| EP-2410977-A1 | COSMETIC COMPOSITION CONTAINING CALCIUM CITRATE AND N-ACYLATED AMINOALCOHOL DERIVATIVE TO PREVENT DRY SKIN AND SIGNS OF CUTANEOUS AGEING | Cognis IP Management GmbH (DE) | 2012-02-01 | — | — | EP | disclosed |
| US-20120016032-A1 | Cosmetic Composition Containing Calcium Citrate And N-Acylated Aminoalcohol Derivative To Prevent Dry Skin And Signs Of Cutaneous Ageing | COGNIS IP MANAGEMENT GMBH (DE) | 2012-01-19 | — | — | US | disclosed |
| WO-2010108619-A1 | COSMETIC COMPOSITION CONTAINING CALCIUM CITRATE AND N-ACYLATED AMINOALCOHOL DERIVATIVE TO PREVENT DRY SKIN AND SIGNS OF CUTANEOUS AGEING | COGNIS IP MANAGEMENT GMBH (DE) | 2010-09-30 | — | — | WO | disclosed |
| EP-2233128-A1 | Cosmetic composition | Cognis IP Management GmbH (DE) | 2010-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140086863-A1 | Cosmetic Composition | ASAH2, ASAH1, GLA | DPP7 1875/4885SIRT6 548/4885SIRT1 257/4885 |
| US-20120016032-A1 | Cosmetic Composition Containing Calcium Citrate And N-Acylated Aminoalcohol Derivative To Prevent Dry Skin And Signs Of Cutaneous Ageing | ASAH2, ASAH1, GLA | DPP7 1484/4885SIRT6 533/4885SIRT1 284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.